Treatment Considerations After New Data: ARASENS, ARANOTE, and PEACE-3

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In part three of this prostate cancer roundtable discussion, the panel examines the latest clinical trials shaping prostate cancer treatment, including ARASENS, ARANOTE, and PEACE-3. This expert panel, moderated by Dr. David Morris, evaluates how these studies may influence the use of doublet and triplet therapies in metastatic hormone-sensitive and castration-resistant prostate cancer. From assessing the safety and efficacy of darolutamide to understanding its role across high- and low-volume disease, the conversation highlights the practical applications of these findings for oncologists in both academic and community settings.
Category
Urology
Be the first to comment

Up Next